Rationale and strategies for reevaluating the ACR20.
暂无分享,去创建一个
[1] M. Dougados,et al. ASsessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis. , 2005, Arthritis and rheumatism.
[2] D. Felson. Whither the ACR20? , 2004, The Journal of rheumatology.
[3] M. Dougados,et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. , 2004, Osteoarthritis and cartilage.
[4] David T Felson,et al. Comparison of rheumatoid arthritis clinical trial outcome measures: a simulation study. , 2003, Arthritis & Rheumatism.
[5] P. Tugwell,et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. , 2003, Rheumatology.
[6] Richard W. Martin,et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. , 2000, The New England journal of medicine.
[7] R A Deyo,et al. Outcome Measures for Low Back Pain Research: A Proposal for Standardized Use , 1998, Spine.
[8] D. Felson,et al. Preliminary definition of improvement in juvenile arthritis. , 1997, Arthritis and rheumatism.
[9] M. Homma. [ACR preliminary definition, of improvement in rheumatoid arthritis]. , 1996, Ryumachi. [Rheumatism].
[10] M. Prevoo,et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. , 1996, Arthritis and rheumatism.
[11] J J Anderson,et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[12] P. Tugwell,et al. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. , 1994, The Journal of rheumatology. Supplement.
[13] J J Anderson,et al. The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials , 1993 .
[14] P Tugwell,et al. Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee. , 1993, The Journal of rheumatology.